Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Aprea Therapeutics, Inc. | StockGist | StockGist

Companies
APRE
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings APRESCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Aprea Therapeutics, Inc.

Filed Jan 28, 2026

Accepted Jan 27, 2026, 7:00 PM ET

CIK 0001781983

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Aprea Therapeutics, Inc.

Person Type

HC

CUSIP: 03836J102

Amendment History

3 filings

SCHEDULE 13G
Original
Nov 17, 20250000935836-25-000708
SCHEDULE 13G/A
Amendment 1
Viewing
Jan 28, 20260001493152-26-003971
SCHEDULE 13G/A
Amendment 2
Latest
Feb 13, 20260001104659-26-015324

Recent Filings

Aprea Therapeutics, Inc.3 days ago

Aprea Therapeutics, Inc.5 days ago

Aprea Therapeutics, Inc.2 weeks ago

Aprea Therapeutics, Inc.2 weeks ago

Aprea Therapeutics, Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice